Skip to search.
 TSX Down 0.01% TSX Ventures Up 0.16%

Novavax, Inc. (NVAX)

-NasdaqGS
8.51 Down 0.13(1.50%) 11:28AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:8.64
Open:8.53
Bid:8.55 x 8200
Ask:8.56 x 800
1y Target Est:10.55
Beta:1.12
Earnings Date:May 5 - May 11 (Est.)
Day's Range:8.45 - 8.60
52wk Range:3.34 - 9.95
Volume:1,162,851
Avg Vol (3m):5,881,990
Market Cap:2.03B
P/E (ttm):N/A
EPS (ttm):-0.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXDown 1.50%2.03B
MRKDown 0.41%164.90B
NVSDown 2.09%237.92B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):67.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.45
Quarterly EPS Est (Mar-15) :-0.11
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback